Medivalent

lanadelumab

WHO ATC code: B06AC05
Also known as: lanadelumab acetate · lanadelumab besylate · lanadelumab calcium · lanadelumab citrate · lanadelumab dihydrochloride · lanadelumab fumarate

Available in 6 countries

United Kingdom7
- Lanadelumab 300mg/2ml solution for injection vialsOTC
- Takhzyro 300mg/2ml solution for injection pre-filled pensOTC
- Takhzyro 150mg/1ml solution for injection pre-filled syringesOTC
See all lanadelumab in United Kingdom →
Canada3
- TAKHZYRO
- TAKHZYRO
- TAKHZYRO
See all lanadelumab in Canada →
Switzerland3
- TAKHZYRO 150 mg
- TAKHZYRO 300 mg
- TAKHZYRO 300 mg
See all lanadelumab in Switzerland →
Spain3
- TAKHZYRO 300 MG SOLUCION INYECTABLE
- TAKHZYRO 150 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA
- TAKHZYRO 300 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA
See all lanadelumab in Spain →
France2
- TAKHZYRO 150 mg, solution injectable en seringue préremplie
- TAKHZYRO 300 mg, solution injectable en seringue préremplie
See all lanadelumab in France →
Netherlands1
- TAKHZYRO 300 mg oplossing voor injectie in voorgevulde spuit
See all lanadelumab in Netherlands →